Dr Kummar on the Evaluation of Rezatapopt in Advanced Solid Tumors

Shivaani Kummar, MD, FACP, discusses the evaluation of rezatapopt in patients with advanced solid tumors.

Related Keywords

Oregon ,United States ,Shivaani Kummar ,Division Of Hematology Medical Oncology ,Oregon Health Science University School Of Medicine ,International Conference On Molecular ,Knight Cancer Institute ,Cancer Research ,Division Head ,Lester Dearmond Endowed Chair ,Medical Oncology ,Oregon Health ,Science University School ,Experimental Therapeutics ,Molecular Targets ,Cancer Therapeutics ,D ,Naacp ,Rezatapopt ,Patients With Advanced Solid Tumors ,